Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects
Status:
Completed
Trial end date:
2020-10-28
Target enrollment:
Participant gender:
Summary
This is a single-center, open, randomized parallel group design study to investigate the
pharmacokinetic characteristics of Mitoxantrone Hydrochloride liposome injection in the
treatment of relapsed/refractory lymphoma after the first administration, and the safety and
efficacy.